Humana faces significant challenges with rising denial rates and customer disenrollment, which have led to a sharp decline in stock value and profitability. Medicare Advantage's struggles, including ...

The healthcare sector is a haven to trade amid market volatility, with the Healthcare sector ETF down only 3.3% YTD compared to the S&P 500's 15% decline. Humana's stock has shown resilience, boosted ...

Humana Inc. HUM recently unveiled a tie-up with Atlas Oncology Partners in a bid to provide enhanced cancer care, ...

Medicare Advantage insurers fully or partially denied 7.4% of prior authorization requests in 2022, an increase compared to the previous three years, according to an analysis by health policy research ...

In 2022, more Medicare Advantage plans will offer nonmedical supplemental benefits that address various social determinants of health such as meals, nutrition, transportation and in-home support ...